PI3Kδ and primary immunodeficiencies

• Associations Between Short‐Term Changes in Disease Activity and Long‐Term Clinical Outcomes in Activated Phosphoinositide 3‐Kinase Delta Syndrome

  2026 Journal of Immunology Research article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

  0

  citations
• Natural history of clinical manifestations in activated phosphoinositide 3-kinase δ syndrome (APDS): Time-to-event analyses using the European Society for Immunodeficiencies-APDS registry

  2025 Clinical Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

  3

  citations
• Systematic literature reviews to identify epidemiological, clinical, economic and health-related quality of life evidence in activated PI3Kδ syndrome (APDS)

  2025 BMC Immunology review Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

  1

  citations
• Phosphoinositide-3-kinase δ as an immune check-pathway in cancer Immunology. Therapeutic prospects

  2025 Expert Review of Clinical Immunology article Biochemistry, Genetics and Molecular Biology PI3K/AKT/mTOR signaling in cancer Open access

  1

  citations
• International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome

  2021 Journal of Allergy and Clinical Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access cited by 2 patents

  74

  citations

5 results